|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 30.69 USD | +3.26% |
|
+21.40% | - |
Company Valuation: Alamar Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2026 | 2027 | 2028 |
|---|---|---|---|
| Market Cap 1 | 2,130 | - | - |
| Change | - | - | - |
| Enterprise Value (EV) 1 | 2,041 | 2,072 | 2,102 |
| Change | - | 1.55% | 1.46% |
| P/E | -25.2x | -44.4x | -86.6x |
| PBR | 5.57x | 7.8x | 7.89x |
| PEG | 0.3x | 1x | 1.8x |
| Capitalization / Revenue | 18x | 12.9x | 9.5x |
| EV / Revenue | 17.2x | 12.5x | 9.38x |
| EV / EBITDA | -37.5x | -44.1x | -215x |
| EV / EBIT | -34.6x | -39.2x | -139x |
| EV / FCF | -23.5x | -42.4x | -101x |
| FCF Yield | -4.26% | -2.36% | -0.99% |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -1.216 | -0.6916 | -0.3542 |
| Distribution rate | - | - | - |
| Net sales 1 | 118.6 | 165.7 | 224.2 |
| EBITDA 1 | -54.4 | -47.02 | -9.78 |
| EBIT 1 | -58.98 | -52.82 | -15.1 |
| Net income 1 | -64.93 | -49.81 | -25.31 |
| Net Debt 1 | -89.09 | -57.53 | -27.23 |
| Reference price 2 | 30.69 | 30.69 | 30.69 |
| Nbr of stocks (in thousands) | 69,393 | - | - |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -25.23x | 17.21x | -37.51x | - | 2.13B | ||
| 34.53x | 5.85x | 22.47x | 0.28% | 249B | ||
| 36.99x | 6.96x | 21.81x | 0.63% | 162B | ||
| 51.68x | 12.65x | 27.12x | -.--% | 157B | ||
| 17.34x | 3.44x | 11.18x | -.--% | 66.22B | ||
| 49.46x | 12.26x | 27.02x | -.--% | 52.3B | ||
| 20.5x | 2.46x | 12.41x | 2.46% | 52.18B | ||
| 35.31x | 7.06x | 22.39x | -.--% | 51.34B | ||
| 33.72x | 6.68x | 22.73x | 0.59% | 48.79B | ||
| 79.42x | 7.56x | 22.95x | -.--% | 44.57B | ||
| Average | 33.37x | 8.21x | 15.26x | 0.44% | 88.56B | |
| Weighted average by Cap. | 38.90x | 7.48x | 21.90x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ALMR Stock
- Valuation Alamar Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
















